Sigachi Industries Ltd
Sigachi Industries Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #10 of 84 in Pharmaceuticals & Biotechnology
See the sector's top 10 — free with your mobile number.
Sigachi Industries Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 Revenue from Operations: Rs. 1,305 Mn.
As stated in Sigachi Industries Ltd's Q2 FY27 investor presentation · published 31 Oct 2026. Reported figures, not investment advice.
Based on Sigachi Industries Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 Revenue from Operations: Rs. Q2 FY27 EBITDA: Rs.
From Sigachi Industries Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.
Revenue & Sales Performance
- Q2 FY27 Revenue from Operations: Rs. 1,305 Mn
- Q2 FY26 Revenue from Operations: Rs. 1,105 Mn
- Year-on-Year (YoY) Revenue Growth: 18.09% (Q2 FY27 vs Q2 FY26)
2 more points from Sigachi Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sigachi Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fast-tracked 12,000 MTPA capacity expansion at Dahej-2 plant.
- Post-expansion, total MCC production capacity will reach 30,000 MTPA.
- Capex amounts over recent years (Rs. Mn): FY22: 243, FY23: 1,007, FY24: 852, FY25: 433, FY26: 412 (Page 21).
- The Dahej facility is situated in a Special Economic Zone and dedicated to premium exports.
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sigachi Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Sigachi Industries Ltd said on order book & pipeline — free account, 30 seconds.
Sigachi Industries Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹117 Cr, net loss ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sigachi Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
Others in Pharmaceuticals & Biotechnology this season
- Advanced Enzyme Technologies Ltd (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,145 million, up 16% YoY from ₹1,845 million in Q2 FY26 (Page 13, 5). Key investor presentation takeaways from Advanced Enzym
- IOL Chemicals (Q2 FY27)
Q2 FY27 revenue from operations: ₹795.0 Cr, a 40.1% year-on-year (YoY) increase from ₹567.5 Cr in Q2 FY26 (Page 7). Key investor presentation takeaways from IOL
- Lyka Labs Ltd (Q2 FY27)
Year-on-Year revenue growth for the quarter: approximately 104.5% increase (8,650.89 vs 4,230.94 lakhs). Key results statement takeaways from Lyka Labs Ltd's Q2
- Anuh Pharma Ltd (Q2 FY27)
64.13 lakhs (~0.34% decline). Key results statement takeaways from Anuh Pharma Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sigachi Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sigachi Industries Ltd Q2 FY27 results?
Q2 FY27 Revenue from Operations: Rs. Q2 FY27 EBITDA: Rs.
What is Sigachi Industries Ltd share price analysis?
Sigachi Industries Ltd currently shows a neutral. The stock trades at a P/E of 44.8 with a market cap of ₹1,008 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sigachi Industries Ltd planning capital expenditure?
Fast-tracked 12,000 MTPA capacity expansion at Dahej-2 plant. - Post-expansion, total MCC production capacity will reach 30,000 MTPA. - Capex amounts over recent years (Rs.
Keep Sigachi Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.